Α-Methylphenylalanine

Monoamine metabolism inhibitor From Wikipedia, the free encyclopedia

α-Methylphenylalanine (α-MePhe or AMPA) is an artificial amino acid and a phenethylamine and amphetamine derivative.[1] It is the α-methylated analogue of phenylalanine, the precursor of the catecholamine neurotransmitters, and the amino acid analogue of amphetamine (α-methylphenethylamine), a psychostimulant and monoamine releasing agent.[1]

Other namesα-MePhe; α-Me-Phe; α-Methyl-Phe; AMPA; α-Methyl-L-Phenylalanine
CAS Number
Quick facts Clinical data, Other names ...
α-Methylphenylalanine
Clinical data
Other namesα-MePhe; α-Me-Phe; α-Methyl-Phe; AMPA; α-Methyl-L-Phenylalanine
Drug classTyrosine hydroxylase inhibitor; Phenylalanine hydroxylase inhibitor; Catecholamine depleting agent; Catecholamine releasing agent
Identifiers
  • (2S)-2-amino-2-methyl-3-phenylpropanoic acid
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
Chemical and physical data
FormulaC10H13NO2
Molar mass179.219 g·mol−1
3D model (JSmol)
  • C[C@](CC1=CC=CC=C1)(C(=O)O)N
  • InChI=1S/C10H13NO2/c1-10(11,9(12)13)7-8-5-3-2-4-6-8/h2-6H,7,11H2,1H3,(H,12,13)/t10-/m0/s1
  • Key:HYOWVAAEQCNGLE-JTQLQIEISA-N
Close

α-MePhe is a tyrosine hydroxylase inhibitor, thereby preventing the transformation of tyrosine into L-DOPA, and results in depletion of the catecholamine neurotransmitters.[2] It is also an inhibitor of phenylalanine hydroxylase, and in conjunction with phenylalanine administration, induces hyperphenylalaninemia analogous to that in phenylketonuria in animals.[3][4][5][6][7] The drug is known to produce metaraminol (3,β-dihydroxyamphetamine), a catecholamine releasing agent, as an active metabolite in animals, and this metabolite contributes to its effects.[2][8]

α-MePhe is a substrate of the L-type amino acid transporter 1 (LAT1), which transports it across the blood–brain barrier into the central nervous system.[9][10]

See also

References

Related Articles

Wikiwand AI